Renephra Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Out of Business

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Out of Business

Renephra General Information

Description

Developer of a medical device designed for minimally invasive fluid removal. The company's transdermal fluid removal technology uses a micro-needle combined with negative pressure therapy, enabling medical practitioners to access and remove excess interstitial fluid from the skin.

Contact Information

Website
renephra.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • MedTech Centre, Greenheys
  • Manchester Science Partnerships, Pencroft Way
  • Manchester M15 6JJ
  • England, United Kingdom
Primary Industry
Other Devices and Supplies
Vertical(s)
Corporate Office
  • MedTech Centre, Greenheys
  • Manchester Science Partnerships, Pencroft Way
  • Manchester M15 6JJ
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Renephra Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Out of Business 01-Mar-2022 Completed Out of Business
10. Secondary Transaction - Private Completed Generating Revenue
9. Later Stage VC 09-Sep-2019 Completed Generating Revenue
8. Later Stage VC 22-Mar-2018 Completed Generating Revenue
7. Grant 01-Dec-2017 Completed Generating Revenue
6. Later Stage VC 15-Apr-2016 Completed Generating Revenue
5. Later Stage VC 21-Jan-2015 Completed Generating Revenue
4. Later Stage VC 07-Feb-2013 Completed Startup
3. Early Stage VC 24-Aug-2011 $352K $871K Completed Startup
2. Early Stage VC 18-May-2011 $115K $519K Completed Startup
To view Renephra’s complete valuation and funding history, request access »

Renephra Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 1,026 $0.015300 $104.38 $104.38 1x $104.38 4.17%
Ordinary 4,176 $0.015300 $95.99 $95.99 1x $95.99 16.97%
To view Renephra’s complete cap table history, request access »

Renephra Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a medical device designed for minimally invasive fluid removal. The company's transdermal fluid removal tec
Other Devices and Supplies
Manchester, United Kingdom
5 As of 2021

Pompey, France
 

Ithaca, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Renephra Competitors (10)

One of Renephra’s 10 competitors is NexInlife, a Private Equity-Backed company based in Pompey, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NexInlife Private Equity-Backed Pompey, France
Transonic Private Debt Financed Ithaca, NY
Abiomed Corporate Backed or Acquired Danvers, MA
Confluent Medical Technologies Formerly PE-Backed Scottsdale, AZ
Polares Medical Venture Capital-Backed Palo Alto, CA
You’re viewing 5 of 10 competitors. Get the full list »

Renephra Patents

Renephra Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-6537531-B2 Body fluid extraction device, applicator device and related method Inactive 23-Jan-2014
JP-2017509449-A Body fluid extraction device, applicator device and related methods Active 23-Jan-2014
EP-3096687-A1 Fluid extraction device, applicator device and associated methods Active 23-Jan-2014
EP-3096687-B1 Fluid extraction device, applicator device and associated methods Active 23-Jan-2014
GB-201401133-D0 Fluid extraction device, applicator device and associated methods Inactive 23-Jan-2014 A61B5/150984
To view Renephra’s complete patent history, request access »

Renephra Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Renephra FAQs

  • When was Renephra founded?

    Renephra was founded in 2008.

  • Where is Renephra headquartered?

    Renephra is headquartered in Manchester, United Kingdom.

  • What is the size of Renephra?

    Renephra has 5 total employees.

  • What industry is Renephra in?

    Renephra’s primary industry is Other Devices and Supplies.

  • Is Renephra a private or public company?

    Renephra is a Private company.

  • What is Renephra’s current revenue?

    The current revenue for Renephra is .

  • How much funding has Renephra raised over time?

    Renephra has raised $2.14M.

  • Who are Renephra’s competitors?

    NexInlife, Transonic, Abiomed, Confluent Medical Technologies, and Polares Medical are some of the 10 competitors of Renephra.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process